Tocilizumab May Reduce Mortality in Certain COVID-19 Patients
Two recent trials suggest that immune-damping drugs such as tocilizumab may reduce mortality in patients with severe COVID-19.
Knowledge Area:
SCCM Account Access
SCCM recently updated its digital infrastructure. If you have an existing SCCM account, and have not logged in since November 1, 2024, you will need to create an account with the email address associated with your previous SCCM account. Learn more about SCCM account access here.
Some website functionality may be limited as improvements continue. Please ensure you are logged in for the best experience.